Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori

10.1016/j.jtcme.2019.05.002

Wagih A. El-Shouny；Sameh S. Ali；Hegazy M. Hegazy；Manar K. Abd Elnabi；Asmaa Ali；Jianzhong Sun

Helicobacter pylori ； Drug resistance ； Cytotoxin-associated genes ； Syzygium aromaticum ； Histopathology ； Antibacterial

Journal of Traditional and Complementary Medicine

10卷4期（2020 / 07 / 01）

366 - 377

英文

The Pan-Drug Resistant (PDR), Helicobacter pylori remains an intractable challenge in public health worldwide and this pathogenicity is mainly due to the presence of a cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA). On the other hand, plant extracts such as Syzygium aromaticum contain a diverse array of secondary metabolites, which could be potentially used to combat H. pylori pathogens. To our knowledge, this is the first report on the biomedical potential of S. aromaticum extract against cytotoxin-associated genes producing PDR H. pylori. In this investigation, out of 45 gastric antral biopsy specimens of dyspeptic patients, 20 strains were confirmed as H. pylori. Eight (40%) out of 20 strains were PDR H. pylori while the rest of the strains were Multi-Drug Resistant (MDR) strains. Genotypic analyses of PDR H. pylori strains showed that cagA and vacA genes were found to be 75% and 87.5%, respectively and m2s2 was the most common subtype of vacA gene. S. aromaticum showed a significant higher anti-H. pylori activity compared to that of Cinnamomum zeylanicum and Thymus vulgaris. Eugenol was the major phenolic compound (28.14%) detected in the methanolic extract of S. aromaticum. Clearly, results of the toxicological assessment confirmed the safety of S. aromaticum for use. Hence, these results suggest that S. aromaticum could be a new useful natural antimicrobial agent that could potentially combat cytotoxin genes-producing drug-resistant H. pylori. Moreover, these findings provide a scientific basis for the development of antimicrobial agents from traditional herbal medicines for gastroprotection against gastric ulcer.

1. Ali, SS,El-Zawawy, NA,Al-Tohamy, R,El-Sapagh, S,Mustafa, AM,Sun, J(2019).Lycium shawii Roem. & Schult.: a new bioactive antimicrobial and antioxidant agent to combat multi-drug/pan-drug resistant pathogens of wound burn infections.J Trad Complement Med
   連結：
2. Abadi, ATB,Yamaoka, Y(2018).Helicobacter pylori therapy and clinical perspective.J Glob Antimicrob Resist,14,111-117.
3. Akazawa, Y,Isomoto, H,Matsushima, K(2013).Endoplasmic reticulum stress contributes to Helicobacter pylori VacA-induced apoptosis.PLoS One,8(12),e82322.
4. Ali, SS,Abomohra, A,Sun, J(2017).Effective bio-pretreatment of sawdust waste with a novel microbial consortium for enhanced biomethanation.Bioresour Technol,238,425-432.
5. Ali, SS,Al-Tohamy, R,Sun, J,Wu, J,Huizi, L(2019).Screening and construction of a novel microbial consortium SSA-6 enriched from the gut symbionts of wood-feeding termite, Coptotermes formosanus and its biomass-based biorefineries.Fuel,236,1128-1145.
6. Ali, SS,Kenawy, E,Sonbol, FI(2019).Pharmaceutical potential of a novel chitosan derivative Schiff base with special reference to antibacterial, anti-Biofilm, antioxidant, anti-Inflammatory, hemocompatibility and cytotoxic activities.Pharm Res,36(1),5.
7. Ali, SS,Morsy, R,El-Zawawy, NA,Fareed, MF,Bedaiwy, MY(2017).Synthesized zinc peroxide nanoparticles (ZnO2-NPs): a novel antimicrobial, anti-elastase, antikeratinase, and anti-inflammatory approach toward polymicrobial burn wounds.Int J Nanomed.,12,6059-6073.
8. Ali, SS,Shaaban, MT,Abomohra, A,El-Safity, K(2016).Macroalgal activity against multiple drug resistant Aeromonas hydrophila: a novel treatment study towards enhancement of fish growth performance.Microb Pathog,101,89-95.
9. Ali, SS,Sun, J(2019).Effective thermal pretreatment of water hyacinth (Eichhornia crassipes) for the enhancement of biomethanation: VIT® gene probe technology for microbial community analysis with special reference to methanogenic Archaea.J Environ Chem Eng,7(1),102853.
10. Ali, SS,Wu, J,Xie, R,Zhou, F,Sun, J,Huang, M(2017).Screening and characterizing of xylanolytic and xylose-fermenting yeasts isolated from the wood-feeding termite, Reticulitermes chinenesis.PLoS One,12(7),e0181141.
11. Al-Tohamy, R,Ali, SS,Saad-Allah, K(2018).Phytochemical analysis and assessment of antioxidant and antimicrobial activities of some medicinal plant species from Egyptian flora.J Appl Biomed,16(4),289-300.
12. Amieva, MR,El-Omar, EM(2008).Host-bacterial interactions in Helicobacter pylori infection.Gastroenterology,134(1),306-323.
13. Bachir, M,Allem, R,Tifrit, A(2018).Primary antibiotic resistance and its relationship with cagA and vacA genes in Helicobacter pylori isolates from Algerian patients.Braz J Microbiol,49(3),544-551.
14. Boonyanugomol, W,Chomvarin, C,Hahnvajanawong, C,Sripa, B,Kaparakis-Liaskos, M,Ferrero, RL(2013).Helicobacter pylori cag pathogenicity island (cagPAI) involved in bacterial internalization and IL-8 induced responses via NOD1- and MyD88-dependent mechanisms in human biliary epithelial cells.PLoS One,8(10),e77358.
15. Boukhris, SA,Amarti, A,El Rhazi, K(2013).Helicobacter pylori genotypes associated with gastric histo-pathological damages in a Moroccan population.PLoS One,8(12),e82646.
16. Castillo-Juárez, I,González, V,Jaime-Aguilar, H(2009).Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders.J Ethnopharmacol,122(2),402-405.
17. Chaieb, K,Hajlaoui, H,Zmantar, T(2007).The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review.Phytother Res,21(6),501-506.
18. Chami, F,Chami, N,Bennis, S,Trouillas, J,Remmal, A(2004).Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model.J Antimicrob Chemother,54(5),909-914.
19. Clinical and Laboratory Standard Institute=CLSI(2014).Performance Standards for Antimicrobial Susceptibility Testing: 24th Informational Supplement M 100-S24.Wayne, PA, USA:CLSI.
20. Correa, P(2013).Gastric cancer: overview.Gastroenterol Clin North Am,42(2),211-217.
21. Cortés-Rojas, DF,de Souza, CRF,Oliveira, WP(2014).Clove (Syzygium aromaticum): a precious spice.Asian Pac J Trop Biomed,4(2),90-96.
22. Cover, TL,Blaser, MJ(2009).Helicobacter pylori in health and disease.Gastroenterology,136(6),1863-1873.
23. Dixon, MF,Genta, RM,Yardley, JH,Correa, P(1996).Classification and grading of gastritis: the updated Sydney system.Am J Surg Pathol,20(10),1161-1181.
24. Dursun, M,Yilmaz, S,Yukselen, V,Kilinç, N,Canoruç, F,Tuzcu, A(2004).Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia.Hepato-Gastroenterology,51(60),1732-1735.
25. El Shafay, SM,Ali, SS,El-Sheekh, MM(2016).Antimicrobial activity of some seaweeds species from Red sea, against multidrug resistant bacteria.Egypt J Aquat Res,42,65-74.
26. El Zawawy, NA,Ali, SS(2016).Anti-proteolytic activity of Ganoderma lucidum methanol extract against Pseudomonas aeruginosa.J Infect Dev Countr,10(9),1020-1024.
27. EL-Adawi, HI,Khalil, MA,EL-Sheekh, MM,El-Deeb, NM,Hussein, MZ(2012).Cytotoxicity assay and antioxidant activities of the lactic acid bacterial strains.Afr J Microbiol Res.,6(8),1700-1712.
28. El-Shenawy, A,Diab, M,Shemis, M(2017).Detection of Helicobacter pylori vacA, cagA and iceA1 virulence genes associated with gastric diseases in Egyptian patients.EJMHG.,18(4),365-371.
29. El-Shouny, WA,Ali, SS,Alnabarawy, AM(2016).In vitro antibacterial potential of Rosa Damascena and Terminalia Chebula against bacterial peritonitis.GJBAHS.,5(2),40-49.
30. El-Shouny, WA,Ali, SS,Fayed, SF(2016).The antibacterial activity of Nigella sativa against multidrug resistant Pseudomonas aeruginosa isolated from diabetic wound infections.MATTER: Int J Sci Technol,2(1),113-134.
31. El-Shouny, WA,Ali, SS,Sun, J,Samy, SM,Ali, A(2018).Drug resistance profile and molecular characterization of extended spectrum beta-lactamase (ESβL)-producing Pseudomonas aeruginosa isolated from burn wound infections. Essential oils and their potential for utilization.Microb Pathog,116,301-312.
32. El-Zawawy, NA,Ali, SS(2016).Pyocyanin as anti-tyrosinase and anti tinea corporis: a novel treatment study.Microb Pathog,100,213-220.
33. Eng, NF,Ybazeta, G,Chapman, K(2015).Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in northeastern ontario.Can J Infect Dis Med Microbiol,26(3),137-144.
34. Fu, Y,Zu, Y,Chen, L(2007).Antimicrobial activity of clove and rosemary essential oils alone and in combination.Phytother Res,21(10),989-994.
35. Ghosh, P,Bodhankar, SL(2012).Determination of risk factors and transmission pathways of Helicobacter pylori in asymptomatic subjects in Western India using polymerase chain reaction.Asian Pac J Trop Dis,12-17.
36. Göttke, MU,Fallone, CA,Barkun, AN(2000).Genetic variability determinants of Helicobacter pylori: influence of clinical background and geographic origin of isolates.J Infect Dis.,181(5),1674-1681.
37. Goudarzi, M,Heidary, M,Azad, M,Fazeli, M,Goudarzi, H(2016).Evaluation of antimicrobial susceptibility and integron carriage in Helicobacter pylori isolates from patients.Gastroenterol Hepatol Bed Bench,9(1),S47-S52.
38. Graham, DY(2017).Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.Clevel Clin J Med,84(4),311.
39. Graham, DY,Dore, MP(2016).Helicobacter pylori therapy: a paradigm shift.Expert Rev Anti Infect Ther,14(6),577-585.
40. Graham, DY,Lu, H,Yamaoka, Y(2009).African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths.J Dig Dis.,10(2),77-84.
41. Gülçin, İ(2011).Antioxidant activity of eugenol: a structure-activity relationship study.J Med Food.,14(9),975-985.
42. Hamad, GM,Taha, TH,El-Deeb, NM,Alshehri, AM(2015).Advanced trends in controlling Helicobacter pylori infections using functional and therapeutically supplements in baby milk.J Food Sci Technol,52(12),8156-8163.
43. Han, X,Parker, TL(2017).Anti-inflammatory activity of clove (Eugenia caryophyllata) essential oil in human dermal fibroblasts.Pharm Biol,55(1),1619-1622.
44. Jaka, H,Rhee, JA,Östlundh, L(2018).The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis.BMC Infect Dis.,18(1),193.
45. Karabiber, H,Selimoglu, MA,Otlu, B,Yildirim, O,Ozer, A(2014).Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis.J Pediatr Gastroenterol Nutr,58(5),608-612.
46. Kenawy, E,Ali, SS,Al-Etewy, M,Sun, J,Wu, J,El-Zawawy, N(2019).Synthesis, characterization and biomedical applications of a novel Schiff base on methyl acrylate-functionalized chitosan bearing p-nitrobenzaldehyde groups.Int J Biol Macromol,122,833-843.
47. Kwon, DH,Dore, MP,Kim, JJ(2003).High-level β-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori.Antimicrob Agents Chemother,47(7),2169-2178.
48. Lai, CH,Kuo, CH,Chen, PY,Poon, SK,Chang, CS,Wang, WC(2006).Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates.J Antimicrob Chemother,57(3),466-471.
49. Lawal, TO,Olorunnipa, TA,Adeniyi, BA(2014).Susceptibility testing and bactericidal activities of Theobroma cacao Linn. (cocoa) on Helicobacter pylori in an in vitro study.J Herb Med,4(4),201-207.
50. Li, Y,Xu, C,Zhang, Q,Liu, JY,Tan, RX(2005).In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases.J Ethnopharmacol,98(3),329-333.
51. Maddox, CE,Laur, LM,Tian, L(2010).Antibacterial activity of phenolic compounds against the phytopathogen Xylella fastidiosa.Curr Microbiol,60(1),53.
52. Majumdar, D,Bebb, J(2019).Helicobacter pylori infection and peptic ulcers.Medicine,47(5),292-300.
53. Mohammed, KAK,Abdulkadhim, HM,Noori, SI(2016).Chemical composition and antibacterial effects of clove (Syzygium aromaticum) flowers.Int J Curr Microbiol App Sci,5(2),483-489.
54. Morsy, R,Ali, SS,El-Shetehy, M(2017).Development of hydroxyapatite-chitosan gel sunscreen combating clinical multidrug-resistant bacteria.J Mol Struct,1143,251-258.
55. Nassan, MA,Mohamed, EH,Abdelhafez, S,Ismail, TA(2015).Effect of clove and cinnamon extracts on experimental model of acute hematogenous pyelonephritis in albino rats: immunopathological and antimicrobial study.Int J Immunopathol Pharmacol,28(1),60-68.
56. Nejati, S,Karkhah, A,Darvish, H,Validi, M,Ebrahimpour, S,Nouri, HR(2018).Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.Microb Pathog,117,43-48.
57. Njume, C,Afolayan, AJ,Ndip, RN(2011).Preliminary phytochemical screening and in vitro anti-Helicobacter pylori activity of acetone and aqueous extracts of the stem bark of Sclerocarya birrea (Anacardiaceae).Arch Med Res.,42(3),252-257.
58. Nostro, A,Cellini, L,Bartolomeo, SD(2005).Antibacterial effect of plant extracts against Helicobacter pylori.Phytother Res: J Pharmacol Toxicol,19(3),198-202.
59. Peek, Jr, RM,Miller, GG,Tham, KT,Pérez-Pérez, GI,Cover, TL,Atherton, JC(1995).Detection of Helicobacter pylori gene expression in human gastric mucosa.J Clin Microbiol,33,28-32.
60. Perez-Perez, GI,Van, TN,Huong, DT(2016).Isolation and characterization of Helicobacter pylori recovered from gastric biopsies under anaerobic conditions.Diagn Microbiol Infect Dis.,86,136-140.
61. Qureshi, NN,Gallaher, B,Schiller, NL(2014).Evolution of amoxicillin resistance of Helicobacter pylori in vitro: characterization of resistance mechanisms.Microb Drug Resist,20(6),509-516.
62. Raju, D,Hussey, S,Ang, M(2012).Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans.Gastroenterology,142(5),1160-1171.
63. Rana, R,Wang, SL,Li, J,Wang, YX,Rao, QW,Yang, CQ(2017).Helicobacter pylori infection: a recent approach to diagnosis and management.J Biomed,2(1),45-56.
64. Rasheed, F,Campbell, BJ,Alfizah, H(2014).Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance.Helicobacter,19(5),387-399.
65. Safrudin, I,Maimulyanti, A,Prihadi, AR(2015).Effect of crushing of clove bud (Syzygium aromaticum) and distillation rate on main constituents of the essential oil.Am J Essent Oil Nat Prod,2(3),12-15.
66. Salimon, J,Abdullah, BM,Salih, N(2012).Rubber (Hevea brasiliensis) seed oil toxicity effect and Linamarin compound analysis.Lipids Health Dis,11(1),74.
67. Suzuki, H,Iwasaki, E,Hibi, T(2009).Helicobacter pylori and gastric cancer.Gastric Cancer,12(2),79-87.
68. Suzuki, K,Tanaka, KSH,Yano, T(2019).Deficiency of stomach-type claudin-18 in mice induces gastric tumor formation independent of H. Pylori infection.Cell Mol Gastroenterol Hepatol
69. Tabak, M,Armon, R,Potasman, I,Neeman, I(1996).In vitro inhibition of Helicobacter pylori by extracts of thyme.J Appl Microbiol,80(6),667-672.
70. Tegtmeyer, N,Wessler, S,Backert, S(2011).Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis.FEBS J.,278(8),1190-1202.
71. Ultee, A,Bennik, MHJ,Moezelaar, R(2002).The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus.Appl Environ Microbiol,68(4),1561-1568.
72. Wu, W,Yang, Y,Sun, G(2012).Recent insights into antibiotic resistance in Helicobacter pylori eradication.Gastroenterol Res Pract,2012
73. Yamaoka, Y(2010).Mechanisms of disease: Helicobacter pylori virulence factors.Nat Rev Gastroenterol Hepatol,7(11),629-641.
74. Yamaoka, Y,Graham, DY(2014).Helicobacter pylori virulence and cancer pathogenesis.Future Oncol,10(8),1487-1500.
75. Yamaoka, Y,Kato, M,Asaka, M(2008).Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains.Intern Med.,47,1077-1083.
76. Yamaoka, Y,Kodama, T,Kashima, K,Graham, DY,Sepulveda, AR(1998).Variants of the 3’ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases.J Clin Microbiol,36(8),2258-2263.
77. Zaidi, SF,Muhammad, JS,Shahryar, S(2012).Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pyloriinfected gastric epithelial cells.J Ethnopharmacol,141(1),403-410.